Published in Health and Medicine Week, July 26th, 2004
"The development of new therapies for treatment of chronic wounds has not matched the availability of treatment modalities forecast by the pharmaceutical industry," investigators in the United States report. "This is attributable in large part to difficulties encountered in clinical trials as well as in isolating study design variables. Our hypothesis attempts to address this shortcoming."
T. Mustoe and colleagues, Northwestern University, explained "We are proposing that chronic wound pathogenesis is based on three fundamental factors: the cellular and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week